Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVOX Defiance Daily Target 2X Long NVO ETF

Market Closed 03-27 16:00:00 EDT

9.28

-0.22

-2.32%

盘后9.29

+0.01+0.11%

19:48 EDT

High9.53	Low9.23	Vol855.78K
Open9.44	D1 Closing9.50	Amplitude3.16%
Mkt Cap42.67M	Tradable Cap42.67M	Total Shares4.60M
T/O8.06M	T/O Rate18.61%	Tradable Shares4.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":9.28,"timestamp":1774641600000,"preClose":9.5,"halted":0,"volume":855784,"hourTrading":{"tag":"盘后","latestPrice":9.29,"preClose":9.28,"latestTime":"19:48 EDT","volume":43233,"amount":402218.0819,"timestamp":1774655316593,"change":0.01,"changeRate":0.001078,"amplitude":0.00431},"delay":0,"changeRate":-0.023157894736842172,"floatShares":4598101,"shares":4598101,"eps":0,"marketStatus":"Market Closed","change":-0.22,"latestTime":"03-27 16:00:00 EDT","open":9.44,"high":9.53,"low":9.23,"amount":8061953.393847999,"amplitude":0.031579,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":9.5,"sharesOutstanding":4098101,"nav":9.51,"aum":43727940.51,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":9.51,"preClose":9.5,"latestTime":"09:25 EDT","volume":46641,"amount":448199.48796,"timestamp":1774617946734,"change":0.01,"changeRate":0.001053,"amplitude":0.042105},"postHourTrading":{"tag":"盘后","latestPrice":9.29,"preClose":9.28,"latestTime":"19:48 EDT","volume":43233,"amount":402218.0819,"timestamp":1774655316593,"change":0.01,"changeRate":0.001078,"amplitude":0.00431},"volumeRatio":0.705766,"impliedVol":0.9565,"impliedVolPercentile":0.656},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"2622877076","title":"Mixed options sentiment in Novo Nordisk with shares down 1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622877076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622877076?lang=en_us&edition=fundamental","pubTime":"2026-03-28 03:26","pubTimestamp":1774639580,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in Novo Nordisk (NVO), with shares down 40c near $36.01. Options volume roughly in line with average with 92k contracts tra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-novo-nordisk-with-shares-down-1-09-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-novo-nordisk-with-shares-down-1-09-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4588","NVOX","LU1093756168.USD","NVO","NVOH","BK4599","IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2622922871","title":"Novo Nordisk A/S Stock Falls Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2622922871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622922871?lang=en_us&edition=fundamental","pubTime":"2026-03-28 01:02","pubTimestamp":1774630920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 0.9% to DKK228.50 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.6% to 2,355.46.The company closed DKK304.90 short of its 52-week high of DKK533.40, which the company reached on June 13, 2025.Trading volume was 7,120,404, compared to the 50-day average trading volume of 9,025,654.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","LU1093756168.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","NVO","BK4532","BK4588","BK4585","BK4599","BK4007","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2622682840","title":"Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages","url":"https://stock-news.laohu8.com/highlight/detail?id=2622682840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622682840?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:05","pubTimestamp":1774605925,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Maria Ripps from Canaccord Genuity mai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-hims-hers-undervalued-growth-leveraging-novo-nordisk-glp-1-partnership-and-scale-advantages-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-hims-hers-undervalued-growth-leveraging-novo-nordisk-glp-1-partnership-and-scale-advantages-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","NVOX","LU0154236417.USD","BK4590","BK4599","BK4144","BK4581","XBI","LU1093756168.USD","BK4588","HIMS","IE00BZ1G4Q59.USD","BK4007","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","NVOH","LABU"],"gpt_icon":0},{"id":"2622903528","title":"Novo Nordisk says Awiql approved by FDA in type 2 diabetes patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2622903528","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622903528?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:51","pubTimestamp":1774569092,"startTime":"0","endTime":"0","summary":"The company states: “Novo Nordisk (NVO) announced that the FDA has approved Awiqli injection 700 units/mL, the first and only once-weekly, long-act...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-awiql-approved-by-fda-in-type-2-diabetes-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-says-awiql-approved-by-fda-in-type-2-diabetes-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756168.USD","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","NVO","NVOX","BK4588","BK4585","LU0154236417.USD","BK4599"],"gpt_icon":0},{"id":"2622936258","title":"HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2622936258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622936258?lang=en_us&edition=fundamental","pubTime":"2026-03-27 02:30","pubTimestamp":1774549854,"startTime":"0","endTime":"0","summary":"Low-cost healthcare services provider Hims & Hers ($HIMS) on Thursday disclosed the availability of approved versions of Novo Nordisk’s ($NVO) GLP-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-stock-slides-after-wegovy-subscription-launch-bofa-sees-31-drop-in-glp-1-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-stock-slides-after-wegovy-subscription-launch-bofa-sees-31-drop-in-glp-1-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","BK4196","BK4144","HIMY","IE00BZ1G4Q59.USD","HIMS","NVOX","LU1093756168.USD","BK4532","BK4588","BK4599","HIMZ","BK4550","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","BK4590","LU0154236417.USD","NVOH","HIYY","BK4007"],"gpt_icon":0},{"id":"2622569898","title":"What's Happening With Novo Nordisk Stock Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622569898","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622569898?lang=en_us&edition=fundamental","pubTime":"2026-03-27 01:47","pubTimestamp":1774547220,"startTime":"0","endTime":"0","summary":"Novo Nordisk A/S (NYSE:NVO) shares are moving higher on Thursday. Hims & Hers Health Inc (NYSE:HIMS) announced it will begin offering several of the Novo's FDA‑approved GLP‑1 medications, including the newly launched Wegovy pill.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/26/Novo-Nordisk-Logo-Displayed-On-Smartphon.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/26/Novo-Nordisk-Logo-Displayed-On-Smartphon.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51490943/whats-happening-with-novo-nordisk-stock-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51490943/whats-happening-with-novo-nordisk-stock-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVOX","BK4599","NVO","LU1093756325.SGD","NVOH","BK4007","BK4532","LU0154236417.USD","LU1093756168.USD","BK4588","BK4585"],"gpt_icon":1},{"id":"2622607408","title":"Novo Nordisk AGM Backs 2025 Dividend, Expands Capital Mandates and Refreshes Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2622607408","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622607408?lang=en_us&edition=fundamental","pubTime":"2026-03-27 01:28","pubTimestamp":1774546120,"startTime":"0","endTime":"0","summary":"The latest update is out from Novo Nordisk ( ($NVO) ). Novo Nordisk held its Annual General Meeting in Bagsværd, Denmark, on 26 March 2026, approvi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-agm-backs-2025-dividend-expands-capital-mandates-and-refreshes-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-agm-backs-2025-dividend-expands-capital-mandates-and-refreshes-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4588","BK4599","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4585","BK4007","NVO","BK4195","NVOX","IE00BZ1G4Q59.USD","NVOH","BK4229"],"gpt_icon":0},{"id":"2622867799","title":"Novo Nordisk Shareholders Approve Dividend, Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2622867799","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622867799?lang=en_us&edition=fundamental","pubTime":"2026-03-27 01:07","pubTimestamp":1774544838,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Thursday shareholders at its annual general meeting approved a total 2025 dividend of 11.70 Danish kroner per share , including a final dividend of 7.95 Danish kroner to be paid in March.Shareholders re-elected Lars Rebien Sorensen as chair and authorized the company to repurchase up to 10% of its share capital. Investors also approved an extension of the board's authorization to increase share capital until April 2028, according to the company.Shares of Novo Nordisk were up 1.6% in Thursday trading.Price: 36.91, Change: +0.58, Percent Change: +1.60","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOX","BK4588","BK7104","BK4532","BK4585","LU1093756325.SGD","NVO","BK4599","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","LU1093756168.USD"],"gpt_icon":1},{"id":"2622715862","title":"Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership","url":"https://stock-news.laohu8.com/highlight/detail?id=2622715862","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622715862?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:23","pubTimestamp":1774542180,"startTime":"0","endTime":"0","summary":"Hims & Hers Health will be selling some of Novo Nordisk's GLP-1 medications, including Wegovy.Starting Thursday, eligible customers can access Wegovy pills and injections in several different dosage amounts. Ozempic injection pens, which are approved for treating diabetes but not obesity, also will be available.Prices start as low as $149 a month, Hims & Hers said.The health platform also is introducing a new membership specifically for weight loss. The membership will include support services, 24/7 direct access to providers, personalized nutrition guidance, ongoing clinical check-ins and peer support.Membership starts at $39 for the first month and $149 each month after.Medication costs are separate and may be covered under the customers' HSA and FSA plan.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hims & Hers Health to Sell Wegovy, Ozempic, Launch Weight-Loss Membership","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","HIMY","HMYY","IE00BKVL7J92.USD","NVOX","HIYY","BK4599","LU1093756325.SGD","NVOH","BK4007","BK4196","BK4532","LU0154236417.USD","LU1093756168.USD","HIMZ","HIMS","BK4588","BK4585"],"gpt_icon":1},{"id":"2622864495","title":"Novo Nordisk announces resolutions from annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622864495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622864495?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:31","pubTimestamp":1774539065,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announces the resolutions at its annual meeting. The company received authorization until the annual meeting in 2027 to repurcha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-resolutions-from-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-resolutions-from-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","BK4588","BK4007","BK4599","BK4585","LU1093756325.SGD","NVO","NVOH","BK4532","IE00BKVL7J92.USD","NVOX"],"gpt_icon":0},{"id":"2622616488","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2622616488","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622616488?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:01","pubTimestamp":1774537315,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.56% to 1,718.19 on the S&P Europe Select ADR Index, which is still up 0.2% for the week","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4599","BK4588","BK4007","LU0084288595.USD","SAN","IE00BZ1G4Q59.USD","NVOX","AFG","TRIB","BK4208","BK4023","CRTO","IE00BKVL7J92.USD","LYG","IE00BFMHRM44.USD","BK4139","DAVA","BK7104","LU0648005311.SGD","LU1093756168.USD","BK4134","BK7142","BK7505","NVO.AU","ING","BK7141","DAVA.AU","LU1093756325.SGD","BK4082","LU0154236417.USD","NVO","BK4207","SAN.AU","BK4585","BK4107","BK4009","ING.AU","CLLS","AKTX","OPRA","NVOH","NGG","BDRX","EDAP","BK4521","BBVA","BK4117","BCS","SLN"],"gpt_icon":1},{"id":"2622869180","title":"Deutsche Bank  Reaffirms Their Hold Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622869180?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:25","pubTimestamp":1774535141,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK275.00. Accor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-reaffirms-their-hold-rating-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-reaffirms-their-hold-rating-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4007","NVO","LU0154236417.USD","BK4585","BK4118","LU1093756168.USD","LU1093756325.SGD","BK4532","BK4588","IE00BKVL7J92.USD","NVOX","IE00BZ1G4Q59.USD","NVOH","BK4552","BK4599"],"gpt_icon":0},{"id":"2622869155","title":"Novo Nordisk call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622869155?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:25","pubTimestamp":1774535114,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novo Nordisk (NVO) with 20,726 calls trading, 1.5x expected, and implied vol increasing over 1 point to 44.93%. 3/2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","NVO","LU1093756325.SGD","BK4599","BK4007","IE00BZ1G4Q59.USD","BK4588","BK4585","LU1093756168.USD","NVOX","BK4532","NVOH","LU0154236417.USD"],"gpt_icon":0},{"id":"2622600349","title":"Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2622600349","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622600349?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:02","pubTimestamp":1774458120,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 0.9% to DKK235.80 Wednesday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.7% to 2,418.58.The company closed DKK297.60 short of its 52-week high of DKK533.40, which the company reached on June 13, 2025.Trading volume was 4,866,342, compared to the 50-day average trading volume of 9,036,682.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1093756325.SGD","IE00BKVL7J92.USD","NVO","NVOX","NVOH","BK4585","BK4588","IE00BZ1G4Q59.USD","BK4532","BK4599","LU1093756168.USD","LU0154236417.USD"],"gpt_icon":1},{"id":"2622071184","title":"Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071184","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071184?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:36","pubTimestamp":1774445760,"startTime":"0","endTime":"0","summary":"Novo Nordisk says UBT251 cuts blood sugar levels and weight more than semaglutide in a Chinese phase 2 trial.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/25/Valparaiso-In-Usa---March-21--2024-Ozemp.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/25/Valparaiso-In-Usa---March-21--2024-Ozemp.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51455910/is-novo-nordisks-experimental-obesity-drug-outperforming-semaglutide","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51455910/is-novo-nordisks-experimental-obesity-drug-outperforming-semaglutide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","BK4532","LU1093756168.USD","BK4588","BK4585","NVO","NVOH","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","LU0154236417.USD","NVOX","LU1093756325.SGD"],"gpt_icon":1},{"id":"2622207899","title":"J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622207899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622207899?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:36","pubTimestamp":1774438595,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Novo Nordisk, with a price target of DKK250.00. According t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0795875086.SGD","LU2028103732.USD","LU2089284900.SGD","LU2111349929.HKD","BK4588","LU0971096721.USD","LU1989772840.SGD","BK4534","IE00BZ1G4Q59.USD","LU1732799900.SGD","LU1162221912.USD","NVOX","LU1244550494.USD","LU0795875169.SGD","LU1548497426.USD","LU1989772923.USD","LU1791710582.SGD","LU2023251221.USD","LU0528227936.USD","LU1720051017.SGD","LU0267386448.USD","LU0882574139.USD","NVOH","BK4599","LU2271345857.HKD","BK4007","LU2133065610.SGD","LU0158827781.USD","LU0314104364.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU0158827948.USD","BK4504","LU0106261372.USD","LU1732800096.USD","LU1720051108.HKD","LU0006306889.USD","LU0154236417.USD","BK4516","BK4127","LU1363072403.SGD","NVO","LU0106831901.USD","LU2089283258.USD","BK4532","LU0557290698.USD","LU0098860793.USD","LU2347655156.SGD","LU1093756325.SGD","LU1791710400.SGD","LU1244550221.USD","LU1074936037.SGD","LU0912757837.SGD","LU1668664300.SGD","LU2357305700.SGD","LU0225283273.USD","LU0234570918.USD","BK4581","BK4585","LU1244550577.SGD"],"gpt_icon":0},{"id":"2622304015","title":"Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622304015","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622304015?lang=en_us&edition=fundamental","pubTime":"2026-03-25 15:14","pubTimestamp":1774422840,"startTime":"0","endTime":"0","summary":"Novo Nordisk said Wednesday that an experimental drug it is developing with Chinese pharmaceutical company The United Bio-Technology  Co. showed \"positive\" results with a mean body weight reduction of up to 9.8% after a 24-week trial.The Danish drugmaker agreed to pay up to $2 billion for the rights to the developmental weight-loss and obesity drug last year as it looks to boost its pipeline of next-generation drugs.The exclusive global licensing deal for UBT251--a drug that targets three different hormones to treat obesity, Type 2 diabetes, and other diseases--means Novo Nordisk has exclusive rights to develop, manufacture, and commercialize UBT251 globally, excluding the Chinese mainland, Hong Kong, Macau and Taiwan.UBT251 differs from Novo Nordisk's current portfolio as it takes a three-pronged approach to weight-loss and blood-sugar control. It combines a GLP-1--the same class of drugs as Novo Nordisk's blockbuster Wegovy and Ozempic--with GIP to reduce appetite and blood sugar, an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results -- Update","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","NVOX","LU0154236417.USD","BK4599","NVO","LU1093756325.SGD","LU1093756168.USD","BK4588","IE00BZ1G4Q59.USD","BK4007","BK4585","IE00BKVL7J92.USD","BK1191","NVOH"],"gpt_icon":1},{"id":"2621150088","title":"Novo Nordisk A/S Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2621150088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621150088?lang=en_us&edition=fundamental","pubTime":"2026-03-24 01:02","pubTimestamp":1774285320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 0.9% to DKK235.30 Monday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.5% to 2,388.62.This was the stock's fourth consecutive day of losses.The company closed DKK298.10 below its 52-week high of DKK533.40, which the company achieved on June 13, 2025.Trading volume was 5,407,216, compared to the 50-day average trading volume of 9,076,058.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","NVOH","BK4585","NVO","BK4588","LU1093756325.SGD","NVOX","IE00BKVL7J92.USD","BK4007","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532"],"gpt_icon":1},{"id":"2621108708","title":"Norway's Oil Fund to Abstain From Voting for Re-Election of Novo Nordisk Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2621108708","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621108708?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:55","pubTimestamp":1774266900,"startTime":"0","endTime":"0","summary":"Norway's $2 trillion sovereign-wealth fund won't support the re-election of Lars Rebien Sorensen as chairman of Novo Nordisk's board at the company's annual general meeting later this week.Norges Bank Investment Management--the arm of Norway's central bank that manages the world's largest sovereign-wealth fund, commonly known as the oil fund--will abstain from the vote, citing \"concern regarding effective boards or shareholder protection.\". NBIM also abstained from the vote to appoint Sorensen to the position at an extraordinary general meeting in November.The oil fund held a 1.6% stake in the Danish drugmaker at the end of last year, according to the most recent figures available.NBIM votes according to a set of guidelines that it says seek to further the long-term economic performance of its investments and reduce financial risks associated with the governance of companies and their environmental and social practices.The guidelines include stipulations for board independence to avoid","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVO","BK4588","BK4599","BK4532","LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","IE00BKVL7J92.USD","LU1093756325.SGD","NVOX","BK4585"],"gpt_icon":1},{"id":"2621708289","title":"Lexicon, Novo Nordisk announce initiation of LX9851 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708289?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:46","pubTimestamp":1774266397,"startTime":"0","endTime":"0","summary":"Lexicon (LXRX) and Novo Nordisk (NVO) announced that Novo Nordisk has initiated a Phase 1 study with LX9851, an oral non-incretin development candi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicon-novo-nordisk-announce-initiation-of-lx9851-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicon-novo-nordisk-announce-initiation-of-lx9851-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4588","BK4585","NVO","NVOX","BK4139","LU1093756168.USD","LXRX","IE00BKVL7J92.USD","LU1093756325.SGD","NVOH","BK4599"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0313},{"period":"1month","weight":-0.1319},{"period":"3month","weight":-0.6005},{"period":"6month","weight":-0.6751},{"period":"1year","weight":-0.8378},{"period":"ytd","weight":-0.5761}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long NVO ETF","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Defiance Daily Target 2X Long NVO ETF,NVOX,Defiance Daily Target 2X Long NVO ETF股票,Defiance Daily Target 2X Long NVO ETF股票老虎,Defiance Daily Target 2X Long NVO ETF股票老虎国际,Defiance Daily Target 2X Long NVO ETF行情,Defiance Daily Target 2X Long NVO ETF股票行情,Defiance Daily Target 2X Long NVO ETF股价,Defiance Daily Target 2X Long NVO ETF股市,Defiance Daily Target 2X Long NVO ETF股票价格,Defiance Daily Target 2X Long NVO ETF股票交易,Defiance Daily Target 2X Long NVO ETF股票购买,Defiance Daily Target 2X Long NVO ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}